Healthcare Sector

VRTX

Market Tracker

  • VRTX (Selected)

    Vertex Pharmaceuticals Incorporated

VRTX Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

VRTX Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

VRTX Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

VRTX Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/15/2027 PUT $340.00 881 +549 +165.36%
05/22/2026 PUT $325.00 251 +251
05/29/2026 PUT $325.00 251 +251
05/22/2026 PUT $370.00 250 +250
05/29/2026 PUT $370.00 250 +250
01/15/2027 CALL $540.00 272 +217 +394.55%
07/17/2026 CALL $520.00 31 -6 -16.22%
12/18/2026 CALL $700.00 417 -10 -2.34%
01/15/2027 CALL $700.00 428 -11 -2.51%
12/18/2026 CALL $740.00 168 -12 -6.67%
01/15/2027 CALL $740.00 128 -12 -8.57%
06/18/2026 CALL $500.00 787 -14 -1.75%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

VRTX Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.04% 7.8M 2.7B
Vanguard 500 Index Fund 2.31% 5.93M 2.05B
Growth Fund Of America Inc 1.99% 5.12M 1.77B
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 1.31% 3.38M 1.17B
Fidelity Contrafund Inc 1.27% 3.26M 1.13B
Vanguard Specialized-Health Care Fund 1.24% 3.18M 1.1B
Fidelity 500 Index Fund 1.09% 2.81M 973.81M
SPDR S&P 500 ETF Trust 1.08% 2.78M 963.23M
New Perspective Fund Inc 1.03% 2.64M 914.72M
American Balanced Fund 0.89% 2.3M 795.94M

VRTX News

  • CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy?

    04/21 01:30 pm

    The Motley Fool

    Read more
  • Is Vertex Pharmaceuticals' Empire in Trouble?

    04/16 03:26 pm

    The Motley Fool

    Read more
  • Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells

    04/10 09:55 am

    Benzinga

    Read more
  • Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications

    04/07 01:44 pm

    GlobeNewswire Inc.

    Read more
  • Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight

    04/06 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Where Will Vertex Pharmaceuticals Be in 1 Year?

    03/25 04:02 pm

    The Motley Fool

    Read more
  • Anti-Aging Protein Research Takes a Step Forward with Cell Cloning

    03/24 11:05 am

    Benzinga

    Read more
  • CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now?

    03/23 01:30 pm

    The Motley Fool

    Read more
  • My Top 3 Drug Stocks for March 2026

    03/20 06:30 am

    The Motley Fool

    Read more
  • Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals

    03/19 02:30 pm

    The Motley Fool

    Read more
  • UNCF NEW ENGLAND Raises Record-Breaking $800,000 for HBCUs and Student Success

    03/19 07:00 am

    GlobeNewswire Inc.

    Read more
  • Is Vertex Pharmaceuticals Heading to $600?

    03/15 09:15 pm

    The Motley Fool

    Read more
  • Oil Crashes 10%, Stocks Rebound On Trump End-Of-War Signals: What's Moving Markets Tuesday?

    03/10 01:03 pm

    Benzinga

    Read more
  • Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps

    03/10 09:24 am

    Benzinga

    Read more
  • 2 Biotech Giants to Buy in 2026

    03/05 09:15 am

    The Motley Fool

    Read more
  • Forget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of

    03/04 02:23 pm

    The Motley Fool

    Read more
  • Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

    03/03 09:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Top Healthcare Stocks to Buy in February

    02/26 03:15 pm

    The Motley Fool

    Read more
  • Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline

    02/26 02:30 pm

    The Motley Fool

    Read more
  • The Ultimate Biotech Stock to Buy With $500 Right Now

    02/24 04:30 am

    The Motley Fool

    Read more
  • Could Vertex Stock Help Turn $100,000 Into $1 Million by 2036?

    02/22 07:30 pm

    The Motley Fool

    Read more
  • CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows

    02/20 11:22 am

    Investing.com

    Read more
  • The Blastoff-Ready Biotech Stock You'll Kick Yourself for Not Buying in 2026

    02/13 04:10 pm

    The Motley Fool

    Read more
  • Small Caps, Silver Rally As Inflation Cools Further: What's Moving Markets Friday?

    02/13 02:48 pm

    Benzinga

    Read more
  • CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens

    02/13 02:45 pm

    Benzinga

    Read more
  • 1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell

    02/10 02:15 pm

    The Motley Fool

    Read more
  • Should You Buy Vertex Before Feb. 12?

    02/10 10:35 am

    The Motley Fool

    Read more
  • Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

    02/03 02:56 am

    GlobeNewswire Inc.

    Read more
  • Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica

    01/27 02:43 pm

    GlobeNewswire Inc.

    Read more
  • Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets

    01/23 01:56 pm

    GlobeNewswire Inc.

    Read more
  • Stock Market Today, Jan. 15: ImmunityBio Surges After Anktiva Revenue Jumps 700%

    01/15 06:27 pm

    The Motley Fool

    Read more
  • Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

    01/14 12:15 pm

    The Motley Fool

    Read more
  • Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026

    01/09 10:30 am

    The Motley Fool

    Read more
  • Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases

    01/08 08:00 am

    GlobeNewswire Inc.

    Read more
  • My 10 Top Stocks to Buy to Start the New Year Off Right

    01/05 09:15 pm

    The Motley Fool

    Read more
  • Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize

    01/02 02:29 pm

    Benzinga

    Read more
  • 3 Supercharged Growth Stocks to Buy and Hold Into the 2030s

    12/28 02:13 pm

    The Motley Fool

    Read more
  • Is CRISPR Therapeutics Stock Yesterday's News?

    12/24 05:15 am

    The Motley Fool

    Read more
  • 12 Days of Investing: My Top 12 Stocks to Buy Before 2026

    12/15 12:10 pm

    The Motley Fool

    Read more
  • 2 Stocks That Could Soar by 52% and 282%, According to Wall Street

    12/07 10:25 am

    The Motley Fool

    Read more
  • Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?

    12/06 08:15 pm

    The Motley Fool

    Read more
  • 1 Reason I'll Never Sell Vertex Pharmaceuticals Stock

    12/04 04:10 pm

    The Motley Fool

    Read more
  • Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight

    12/03 02:00 pm

    GlobeNewswire Inc.

    Read more
  • 2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

    12/03 07:15 am

    The Motley Fool

    Read more
  • Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50%

    11/30 05:10 am

    The Motley Fool

    Read more
  • Where Will Vertex Pharmaceuticals Be in 5 Years

    11/27 07:31 am

    The Motley Fool

    Read more
  • 2 Healthcare Stocks For Beginner Investors With a 30-Year Time Horizon

    11/23 11:28 am

    The Motley Fool

    Read more
  • 1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November

    11/17 08:15 am

    The Motley Fool

    Read more
  • My 3 Favorite Stocks to Buy Right Now

    11/16 10:30 am

    The Motley Fool

    Read more
  • Neuer Europachef bei Vertex treibt Produktinnovationen voran und stärkt Lösungen für Compliance

    10/30 04:00 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: